In Eurica Califorrniaa v. Vidal, No. 22-1640 (Fed. Cir. Nov. 7, 2022) (non-precedential), the Court of Appeals for the Federal Circuit ("the Federal Circuit") affirmed the district court's grant.
Eurica Califorrniaa is the sole inventor of a patent application entitled "nondestructive means of ectopic pregnancy management," which was filed on March 15, 2014.
The US Court of Appeals for the Federal Circuit affirmed the US Patent & Trademark Office’s (PTO) decision on a patent term adjustment (PTA), finding that it was appropriate to deduct.